Multidrug resistance-associated protein subfamily transporters and drug resistance

Anti-Cancer Drug Design

Volumn 14, Issue 2, 1999, Pages 123-131

  Kuwano, Michihiko ^a   Toh, Satoshi ^a   Uchiumi, Takeshi ^a   Takano, Hiroshi ^b   Kohno, Kimitoshi ^b   Wada, Morimasa ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

cMOAT; MRP; Multidrug resistance; Transporter

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; MULTIDRUG RESISTANCE PROTEIN;

CELL LINE; DNA TRANSFECTION; GENE ISOLATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW;

ANIMALS; ANION TRANSPORT PROTEINS; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; DRUG RESISTANCE, NEOPLASM; GENES, MDR; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 0344258381     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Abe T., Hasegawa S., Taniguchi K., Yokomizo A., Kuwano T., Ono M., Mori T., Hori S., Kohno K., Kuwano M. (1994) Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. International Journal of Cancer, 58, 860.
2. Akiyama S., Fojo A.T., Hanover J.A., Pastan I, Gottesman M.M. (1985) Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell and Molecular Genetics, 11, 117.
3. Alvarez M., Paull K., Monks A., Hose C., Lee J.S., Weinstein J., Grever M., Bates S., Fojo T. (1995) Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. Journal of Clinical Investigation, 95, 2205.
4. Barrand M.A., Heppell-Parton A.C., Wright K.A., Rabbitts P.H., Twentyman P.R. (1994) A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. Journal of the National Cancer Institute, 86, 110.
5. Beck W.T., Danks M.K., Yalowich J.C. (1987) Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Research, 41, 1297.
6. Bordow S.B., Haber M., Madafiglio J., Cheung B., Marshall G.M., Norris M.D. (1994) Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-mye oncogene in childhood neuroblastoma. Cancer Research, 53, 5036.
7. Breuninger L.M., Paul S., Gaughan K., Miki T., Chan A., Aaronson S.A., Kruh G.D. (1995) Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Research, 55, 5342.
8. Buchler M., Konig J., Brom M., Kartenbeck J., Spring H., Horie T., Keppler D. (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. Journal of Biological Chemistry, 271, 15091.
9. Chen C.-J., Chin J.E., Ueda K., Clark D., Pastan I., Gottesman M.M., Roninson I.B. (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47, 381.
10. Clifford S.C., Neal D.E., Lunee J. (1996) Alterations in expression of the multidrug resistance-association protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. British Journal of Cancer, 73, 659.
11. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V. and Deeley R.G.O. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cell line. Science, 258, 1650.
12. Cole S.P.C., Sparks K.E., Fraser K., Loe D.W., Grant C.E., Wilson G.M., Deeley R. G. (1994) Pharmacological characterization of multidrug resistant MRP transfected human tumor cells. Cancer Research, 54, 5902.
13. Deeley R.G., Cole S.P.C. (1994) Function, evolution and structure of multidrug resistance protein (MRP). Seminars in Cancer Biology, 8, 193.
14. Debenham P.G., Kartner N., Siminovitch L., Riordan J.R., Ling V. (1982) DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Molecular Biology of the Cell, 2, 881.
15. Endo K., Maehara Y., Kusumoto T., Ichiyoshi Y., Kuwano M., Sugimachi K. (1996) Expression of multidrug resistance-associated protein (MRP) and chemo sensitivity in human gastric cancer. International Journal of Cancer, 68, 372.
16. Evers R., Kool M., van Deemter L., Janssen H., Calafat J., Oomen L.C., Paulusma C.C., Oude Elferink R.P., Baas F., Schinkel A.H., Borst P. (1998) Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. Journal of Clinical Investigation, 101, 1310.
17. Filipits M., Suchomel R.W., Dekan G., Haider K., Valdimarson G., Depisch D., Pirker R. (1996) MRP and MDR1 gene expression in primary breast carcinomas. Clincal Cancer Research, 2, 1231.
18. Fujii R., Mutoh M., Sumizawa T., Chen Z.S., Yoshimura A., Akiyama S. (1994) Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. Journal of the National Cancer Institute, 86, 1781.
19. Goldstein L.J., Galski H., Fojo A., Willingham M., Lai S.L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G.M., Lieber M., Cossman J., Gottesman M.M., Pastan I. (1989) Expression of a multidrug resistance gene in human cancers. Journal of the National Cancer Institute, 81, 116.
20. Gottesman M.M., Pastan I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385.
21. Grant C.E., Valdimarsson G., Hipfer D.R., Almquist K.C., Cole S.P.C., Deeley R.G. (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Reseach, 54, 357.
22. Grant C.E., Kurz E.U., Cole S.P., Deeley R.G. (1997) Analysis of the intron-exon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA. Genomics, 45, 368.
23. Gros P., Ben-Neriah Y., Croop J.M., Housman D. (1986) Isolation and expression of complementary DNA that confers multidrug resistance. Nature, 323, 728.
24. Hasegawa S., Abe T., Naito S., Kotoh S., Kumazawa J., Hipfner D.R., Deeley R.G., Cole S.P., Kuwano M. (1995) Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. British Journal of Cancer, 71, 907.
25. Higgins C.F. (1992) ABC transporters: from microorganisms to man. Annual Review of Cell Biology, 8, 67.
26. 2 terminus. Journal of Biological Chemistry, 272, 23623.
27. Hyde S.C., Emsley P., Hartshorn M.J., Mimmack M.M., Gileadi U., Pearce S.R., Gallagher M.P., Gill G.R., Hubbard R.E., Higgins C.F. (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature, 346, 362.
28. Ishikawa T., Ali-Osman F. (1993) Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. Journal of Biological Chemistry, 268, 20116.
29. Ishikawa T., Muller M., Klunemann C., Schaub T., Keppler D. (1990) ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. Journal of Biological Chemistry, 265, 19279.
30. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. (1997) Molecular cloning of canalicular multispecific organic anion transporter defective in ehbr. American Journal of Physiology, 272, G16.
31. Ito K., Fujimori M., Nakata S., Hama Y., Shingu K., Kobayashi S., Tsuchiya S., Kohno K., Kuwano M., Amano J. (1998a) Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer. Oncology Research, 10, 99.
32. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. (1998b) Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. Journal of Biological Chemistry, 273, 1684.
33. Jedlitschky G., Leie I., Buchholz U., Barnouin K., Kurz G., Keppler D. (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Research, 56, 988.
34. Kartner N., Riordan J.R., Ling V. (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285.
35. Keppler D., Kartenbeck J. (1996) The canalicular conjugate export pump encoded by the cmrp/cmoat gene. Progress in Liver Diseases, 14, 55.
36. Kinoshita S., Suzuki H., Ito K., Kume K., Simizu T., Sugiyama Y. (1998) Transfected rat cMOAT is functionally expressed on the apical membrane in Madin-Darby canine kindey cells. Pharmaceutical Research, 15, 1851.
37. Kiuchi Y., Suzuki H., Hirohashi T., Tyson C.A., Sugiyama Y. (1998) cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP). FEBS Letters, 4, 149.
38. Koike K., Abe T., Kubo T., Wada M., Kohno K., Kuwano M. (1996) Overexpression of the multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins. Japanese Journal of Cancer Research, 87, 765.
39. Koike K., Kawabe T., Tanaka T., Toh S., Uchiumi T., Wada M., Akiyama S., Ono M., Kuwano M. (1997) A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Research, 57, 5475.
40. Kool M., de Haas M., Scheffer G.L., Scheper R.J., Vaneijk M., Juijn J.A., Baas F., Borst P. (1997) Analysis of expression of cmoat (mrp2), mrp3, mrp4, and mrp5, homologues of the multidrug resistance-associated protein gene (mrp1), in human cancer cell lines. Cancer Research, 57, 3537.
41. Krishnamachary N., Center M.S. (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Research, 53, 3658.
42. Kruh G.D., Chan A., Myers K., Gaughan K., Miki T., Aaronson S.A. (1994) Expression complementary DNA library transfer establishes MRP as a multidrug resistance gene. Cancer Research, 54, 1649.
43. Kusaba H., Kohno K., Asakuno K., Kuwano M., Okumura K., Green E.D., Schlessinger D., Wada M. (1995) Functional expression of yeast artificial chromosome - human multidrug resistance genes in mouse cells. Genome Research, 5, 245.
44. Kusuhara H., Suzuki H., Sugiyama Y. (1998) The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs. Journal of Pharmaceutical Sciences, 87, 1025.
45. Leier I., Jedlitschky G., Buchholz U., Cole S.P., Deeley R.G., Keppler D. (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. Journal of Biological Chemistry, 269, 27807.
46. Loe D.W., Almquist K.C., Deeley R.G., Cole S.P. (1996a) Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. Journal of Biological Chemistry, 271, 9675.
47. Loe D.W., Deeley R.G., Cole S.P.C. (1996b) Biology of the multidrug resistance protein, MRP. European Journal of Cancer, 32A, 945.
48. Lorico A., Rappa G.M., Finch R.A., Yang D., Flavell R.A., Sartorelli A.C. (1997) Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Research, 57, 5238.
49. Marsh W., Center M.S. (1987) Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells. Cancer Research, 47, 5080.
50. Mirski S.E., Gerlach J.H., Cole S.P. (1987) Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Research, 47, 2594.
51. Muller M., Meijer C., Zaman G.J., Borst P., Scheper R.J., Mulder N.H., de Vries E.G., Jansen P.L. (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proceedings of the National Academy of Sciences, USA, 91, 13033.
52. Nakagawa M., Nomura Y., Kohno K., Ono M., Mizoguchi H., Ogata J., Kuwano M. (1993) Reduction of drug accumulation in cisplatin-resistant variants of human prostatic cancer PC-3 cell line. Journal of Urology, 150, 1970.
53. Nakagawa M., Emoto A., Hanada T., Kuwano M., Cole S.P.C., Nomura Y. (1997) Clinical significance of multidrug resistant protein (MRP) and P-glycoprotein patients with bladder cancers. Journal of Urology, 157, 1260.
54. Nishida T., Gatmaitan Z., Roy-Chowdhry J., Arias I.M. (1992) Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia. Journal of Clinical Investigation, 90, 2130.
55. Nooter K., Sonneveld P., Oostrum R., Herweijer H., Hagenbeek T., Valerio D. (1990) Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A. International Journal of Cancer, 45, 263.
56. Nooter K., Westerman A.M., Flens M.J., Zaman G.J.R., Scheper R., van Wingerden K.E., Burger H., Oostrum R., Boersma T., Sonneveld P., Gratama J.W., Kok T., Eggermont A.M.M., Bosman F.T., Stoter G. (1995) Expression of the multidrug resistance-associated protein (MRP) gene in human cancer. Clinical Cancer Research, 1, 1301.
57. Nooter K., Bosman F.T., Burger H., van Wingerden K.E., Flens M.J., Scheper R.J., Oostrum R.G., Boersma A.W.M., van de Gaast A., Stoter G. (1996) Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Annals of Oncology, 7, 75.
58. Norris M.D., Bordow S.B., Marshall G.M., Haber P.S., Cohn S.L., Haber M. (1996) Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. New England Journal of Medicine, 334, 231.
59. Ota E., Abe Y., Oshika Y., Ozeki Y., Iwasaki M., Inoue H., Yamazaki H., Ueyama Y., Takagi K., Ogata T. (1995) Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. European Journal of Cancer, 72, 550.
60. Oude Elferink R.P., Ottenhoff R., Liefting W.G., Schoemaker B., Groen A.K., Jansen P.L. (1990) ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes. American Journal of Physiology, 258, G699.
61. Paulusma C.C., Bosma P.J., Zaman G.J., Bakke, C.T., Otter M., Scheffer G.L., Scheper R.J., Borst P., Oude Elferink R.P. (1996) Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science, 271, 1126.
62. Paulusma C.C., Kool M., Bosma P.J., Scheffer G.L., Terborg F., Scheper R.J., Tytgat G., Borst P., Baas F., Oude Elferink R.P. (1997) A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology, 25, 1539.
63. Rappa G., Lorico A., Flavell R.A., Sartorelli A.C. (1997) Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Research, 57, 5232.
64. Scheper R.J., Broxterman H.J., Scheffer G.L., Kaaijk P., Dalton W.S., van Heijningen T.H., van Kalken C.K., Slovak M.L., de Vries E.G., van der Valk P. (1993) Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Research, 53, 1475.
65. Slovak M.L., Ho J.P., Bhardwai G., Kurz E.U., Deeley R.G., Cole S.P.C. (1993) Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Reseach, 53, 3221.
66. Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M., Kagotani K., Okumura K., Akiyama S., Kuwano M. (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Research, 56, 4124.
67. Toh S., Wada M., Uchiumi T., Inokuchi A., Makino Y., Horie H., Adachi Y., Sakisaka S., Kuwano M. (1999) Genomic structure of the canalicular multispecific organic anion transporter (cMOAT) gene and mutations in the ATP binding cassette region in Dubin-Johnson syndrome. American Journal of Human Genetics, 64, 739.
68. Tsuruo T. (1988) Mechanisms of multidrug resistance and implications for therapy. Japanese Journal of Cancer Research, 79, 285.
69. Tusnady G.E., Bakos E., Varadi A., Sarkadi B. (1997) Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Letters, 402, 1.
70. Uchiumi T., Hinoshita E., Haga S., Nakamura T., Tanaka T., Toh S., Furukawa M., Kawabe T., Wada M., Kagotani K., Okumura K., Kohno K., Kuwano M. (1998) Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. Biochemical and Biophysical Research Communications, 252, 103.
71. van der Bliek A.M., Baas F., van der Velde-Koerts T., Biedler J.L., Ozols R.F., Hamiltion T.C., Joenje H., Borst P. (1988) Genes amplified and overexpressed in human multidrug resistant cell lines. Cancer Research, 48, 5927.
72. Wada M., Toh S., Taniguchi K., Uchiumi T., Kohno K., Yoshida I., Kimura A., Sakisaka S., Adachi Y., Kuwano M. (1998) Mutation in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Human Molecular Genetics, 7, 203.
73. Wijnholds J., Evers R., van Leusden M.R., Mol C.A.A.M., Zaman G.J., Mayer U., Beijnen J.H., van der Valk M., Krimpenfort P., Borst P. (1991) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Medicine, 3, 1275.
74. Zaman G.J.R., Flens M.J., van Leusden M.R., de Haas M., Müder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proceedings of the National Academy of Sciences, USA, 91, 8822.
75. Zaman G.J., Versantvoort C.H., Smit J.J., Eijdems E.W., de Haas M., Smith A.J., Broxterman H.J., Mulder N.H., de Vries E.G., Baas F., Borst, P. (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Research, 53, 1747.